Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age 18 years or over, of both sexes; having been diagnosed with advanced breast cancer and starting palliative chemotherapy treatment at the SUS clinical oncology clinic at the Erasto Gaertner Hospital; patients diagnosed with stage III or IV advanced breast cancer, regardless of the chemotherapy plan (number of sessions, adverse effects, duration of treatment)
Exclusion criteria
Exclusion criteria: Patients with tumor located in the pinna
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is intended, as the primary outcome of this research, the reduction of side effects from palliative chemotherapy and improvement in the health-related quality of life score of patients with stage III or IV advanced breast cancer. These will be measured by the “QLQ-C30” questionnaire, in the group of patients who underwent the laser auriculotherapy technique and/or guided image relaxation. | — |
Secondary
| Measure | Time frame |
|---|---|
| It is intended, as a secondary outcome, the decrease in anxiety levels, measured through the AGE-TRAIT-STATE questionnaire in the group of patients with stage III or IV advanced breast cancer undergoing palliative chemotherapy, who underwent the technique of auriculotherapy with laser and /or guided image relaxation. ;It is intended, as a secondary outcome, improvement in fatigue indices, measured by the FACT-F questionnaires (version 4), in the group of patients with stage III or IV advanced breast cancer using palliative chemotherapy, who underwent laser auriculotherapy technique and/or image relaxation guided tour. | — |
Countries
Brazil
Contacts
Programa de Pós Graduação em Enfermagem da Universidade Federal do Paraná